April 10th 2025
Study participants treated with elinzanetant experienced significantly reduced hot flash frequency vs paroxetine, desvenlafaxine, and gabapentin in a new meta-analysis.
Chronic Conditions May Be Barrier to Timely Cervical Cancer Screening
Breast Cancer Death Rates Drop, but Racial Disparities Linger